<?xml version="1.0" encoding="UTF-8"?>
<p id="Par21">Considering only very poor mobilizers (CD34+ count ≤ 10/µl), 7 out of 15 patients (47%) in the pre-plerixafor period and 33/40 patients (83%) in the plerixafor period proceeded to transplantation (
 <italic>p</italic> = 0.02). Again, there was no difference between platelet/neutrophil engraftment rates and time to engraftment in those patients proceeding to transplantation (Table 
 <xref rid="Tab5" ref-type="table">5</xref>).
</p>
